Post-Operative Complications in Cardiac Surgery

1
Pipeline Programs
1
Companies
2
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
1
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

1 companies ranked by most advanced pipeline stage

Renibus Therapeutics
Renibus TherapeuticsTX - Southlake
2 programs
1
RBT-1Phase 31 trial
RBT-1N/A1 trial
Active Trials
NCT06092970Active Not RecruitingEst. Jun 2026
NCT06021457CompletedEst. Jun 2025

Trial Timeline

Clinical trial activity over time

2023
2024
2025
2026
Renibus TherapeuticsRBT-1
Renibus TherapeuticsRBT-1

Clinical Trials (2)

Effect of RBT-1 on Reducing the Risk of Post-Operative Complications in Subjects Undergoing Cardiac Surgery

Start: Oct 2023Est. completion: Jun 2025
Phase 3Completed

An Evaluation of Patient Reported Outcomes and Clinical Outcomes

Start: Oct 2023Est. completion: Jun 2026
N/AActive Not Recruiting

Phase Legend

PreclinicalLab & animal studies
Phase 1Safety & dosing
Phase 2Efficacy testing
Phase 3Large-scale trials
On MarketApproved & available

Key Insights

1 late-stage (Phase 3) programs — potential near-term approvals
1 companies competing in this space